Home › NDC Lookup › RxCUI directory › RxCUI 2717320

1 ML meloxicam 30 MG/ML Injection [Xifyrm] — RxCUI 2717320

RxNorm drug concept · Semantic branded drug
RxCUI 2717320 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2717320
Official name1 ML meloxicam 30 MG/ML Injection [Xifyrm]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Xifyrm 30 MG/ML Injection; Xifyrm 30 MG in 1 ML Injection; Xifyrm 30 MG per 1 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meloxicam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meloxicam treats pain and inflammation from osteoarthritis and rheumatoid arthritis in adults. It's also approved for juvenile rheumatoid arthritis in children — the oral suspensio...
  • What conditions is meloxicam actually used to treat?
  • Good news — you can take meloxicam with or without food, so whatever is easiest for you works fine. Taking it with a small snack can help if you find it bothers your stomach. It's...
  • Can I take meloxicam with food, and does it matter what time of day I take it?
📖 Read our full Meloxicam guide →

🕸️ Concept Web — How 1 ML meloxicam 30 MG/ML Injection [Xifyrm] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML meloxicam 30 MG/ML Injection [Xifyrm] RxCUI 2717320

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Meloxicam 41493
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xifyrm 2717316
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meloxicam Injection 2281105
    • Meloxicam Injectable Product 1165106
    • Meloxicam Injection [Xifyrm] 2717319
    • Xifyrm Injectable Product 2717318
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML meloxicam 30 MG/ML Injection SCD · 2281106
  • Meloxicam 30 MG/ML SCDC · 2281104
  • Meloxicam Injection SCDF · 2281105
  • Meloxicam Injectable Product SCDG · 1165106

Brand-Name Concepts

  • Meloxicam 30 MG/ML [Xifyrm] SBDC · 2717317
  • Meloxicam Injection [Xifyrm] SBDF · 2717319
  • Xifyrm Injectable Product SBDG · 2717318
  • Xifyrm BN · 2717316

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2717320 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24338-0153-02 10 VIAL, SINGLE-DOSE in 1 CARTON (24338-153-02) / 1 mL in 1... XIFYRM Azurity Pharmaceuticals, Inc. 2025-06-05
Observed labelers: Azurity Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.